Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Inhibition of methylation and changes in gene expression in relation to neural tube defects

View through CrossRef
AbstractBACKGROUND:An impaired DNA methylation has been suggested to underlie the complex etiology of neural tube defects (NTDs). Previously, we have demonstrated that inhibition of methylation by periodate oxidized adenosine (Adox) results in a widening of the anterior neuropore (ANP) in our in vitro chick embryo model. Since DNA methylation is the chief regulator of gene expression, we hypothesize that inhibition of methylation by Adox in our in vitro chick embryo model will affect the expression of genes that may be involved in neurulation. In the present study, we therefore examined differential gene expression between Adox‐treated and control chick embryos, using the Affymetrix Genechip Chicken Genome Array.METHODS:Chick embryos of 4/5 somites were cultured in vitro with saline (control) or Adox and cranial parts were excised. Gene expression profiling was determined using the Affymetrix Genechip Chicken Genome Array on RNA isolated from two pools of Adox‐treated cranial parts (n = 12) and two pools of saline‐treated cranial parts (n = 12). Microarray data were validated by QPCR analysis.RESULTS:In the Adox‐treated chick embryos, 45 probesets were up‐regulated (fold ≥ 2.0, p < 0.05) and 32 probesets were down‐regulated (fold ≤ 0.5, p < 0.05). Of the 15 genes selected for QPCR analysis, the up‐regulation of phosphoserine phosphatase (PSPH), unc‐51‐like kinase 1 (ULK1), and chemokine (C‐X‐C motif) ligand 12/stromal cell‐derived factor 1 (CXCL12/SDF‐1) was confirmed.CONCLUSIONS:Inhibition of methylation by Adox affects gene expression in our in vitro chick embryo model. Further research will focus on the gene‐specific methylation patterns of PSPH, ULK1, and CXCL12/SDF‐1 and the role of the products of these genes in neurulation. Birth Defects Research (Part A) 82:676–683, 2008. © 2008 Wiley‐Liss, Inc.
Title: Inhibition of methylation and changes in gene expression in relation to neural tube defects
Description:
AbstractBACKGROUND:An impaired DNA methylation has been suggested to underlie the complex etiology of neural tube defects (NTDs).
Previously, we have demonstrated that inhibition of methylation by periodate oxidized adenosine (Adox) results in a widening of the anterior neuropore (ANP) in our in vitro chick embryo model.
Since DNA methylation is the chief regulator of gene expression, we hypothesize that inhibition of methylation by Adox in our in vitro chick embryo model will affect the expression of genes that may be involved in neurulation.
In the present study, we therefore examined differential gene expression between Adox‐treated and control chick embryos, using the Affymetrix Genechip Chicken Genome Array.
METHODS:Chick embryos of 4/5 somites were cultured in vitro with saline (control) or Adox and cranial parts were excised.
Gene expression profiling was determined using the Affymetrix Genechip Chicken Genome Array on RNA isolated from two pools of Adox‐treated cranial parts (n = 12) and two pools of saline‐treated cranial parts (n = 12).
Microarray data were validated by QPCR analysis.
RESULTS:In the Adox‐treated chick embryos, 45 probesets were up‐regulated (fold ≥ 2.
0, p < 0.
05) and 32 probesets were down‐regulated (fold ≤ 0.
5, p < 0.
05).
Of the 15 genes selected for QPCR analysis, the up‐regulation of phosphoserine phosphatase (PSPH), unc‐51‐like kinase 1 (ULK1), and chemokine (C‐X‐C motif) ligand 12/stromal cell‐derived factor 1 (CXCL12/SDF‐1) was confirmed.
CONCLUSIONS:Inhibition of methylation by Adox affects gene expression in our in vitro chick embryo model.
Further research will focus on the gene‐specific methylation patterns of PSPH, ULK1, and CXCL12/SDF‐1 and the role of the products of these genes in neurulation.
Birth Defects Research (Part A) 82:676–683, 2008.
© 2008 Wiley‐Liss, Inc.

Related Results

Correcting Methylation Calls in Clinically Relevant Low-Mappability Regions
Correcting Methylation Calls in Clinically Relevant Low-Mappability Regions
AbstractDNA methylation is an important component in vital biological functions such as embryonic development, carcinogenesis, and heritable regulation. Accurate methods to assess ...
Comparative Promoter Methylation Analysis of p53 Target Genes in Urogenital Cancers
Comparative Promoter Methylation Analysis of p53 Target Genes in Urogenital Cancers
<i>Introduction:</i> The methylation status of selected new p53 target genes in bladder, kidney and testicular cancer was investigated to find similarities in methylati...
Pcgf1 regulates early neural tube development through histone methylation in zebrafish
Pcgf1 regulates early neural tube development through histone methylation in zebrafish
Abstract Objective Early neural tube development in the embryo includes neural induction and self-renewal of neural stem cells (NSCs). The abnormal of neural tube developm...
Prevalence of Neural tube defects at PUMHS Hospital.
Prevalence of Neural tube defects at PUMHS Hospital.
Introduction: Spina bifida, anencephaly, and encephalocele are neural tube defects (NTD) and result from failure of closure of the neural tube between 21and 28 days following conce...
Global DNA methylation and gene expression analysis in pre-B cell acute lymphoblastic leukemia
Global DNA methylation and gene expression analysis in pre-B cell acute lymphoblastic leukemia
Acute lymphoblastic leukemia (ALL) is a hematological cancer associated with precursor B-cells and is the most common cancer diagnosed in children under the age of 15. Our complete...
Abstract 2313: Dynamic expression of 5-alpha reductase 2 in aging prostate is regulated by DNA methyltransferase 1
Abstract 2313: Dynamic expression of 5-alpha reductase 2 in aging prostate is regulated by DNA methyltransferase 1
Abstract BACKGROUND: 5-alpha reductase type 2 (SRD5A2), an enzyme that is critical for prostatic development and growth, is utilized as an inhibitory ...

Back to Top